DC pole | Wartość | Język |
dc.contributor.author | Żur, Joanna | - |
dc.contributor.author | Michalska, Justyna | - |
dc.contributor.author | Piński, Artur | - |
dc.contributor.author | Mrozik, Agnieszka | - |
dc.contributor.author | Nowak, Agnieszka | - |
dc.date.accessioned | 2020-05-22T07:10:11Z | - |
dc.date.available | 2020-05-22T07:10:11Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Water, Vol. 12, Iss. 4 (2020), Art. No. 1133 | pl_PL |
dc.identifier.issn | 2073-4441 | - |
dc.identifier.uri | http://hdl.handle.net/20.500.12128/14185 | - |
dc.description.abstract | In this study, we evaluated the impact of the successive bioaugmentation of the activated
sludge (AS) with the defined bacterial consortium on the activity and functional capacity of the
AS microorganisms. In parallel, the removal of low concentrations of the selected non-steroidal
anti-inflammatory drugs (ibuprofen, naproxen, diclofenac) and analgesic paracetamol was studied.
We found that the addition of the bacterial consortium consisting of three pharmaceuticals-degrading
strains Bacillus thuringiensis B1 (2015b), Stenotrophomonas maltophilia KB2, and Pseudomonas moorei
KB4 into the AS did not cause any significant changes in the biomass abundance and metabolic
activity of the AS microorganisms. Although, the successive bioaugmentation of the AS caused a
slight increase in the metabolic diversity, the intensity of carbohydrates usage, and metabolic richness.
Microorganisms in the bioaugmented and non-bioaugmented AS were able to degrade the mixture of
the analyzed drugs with similar e ciency, however, diclofenac was removed more e ectively in the
bioaugmented AS. Several metabolites were identified and e ciently utilized, with the exception of
4-OH diclofenac. Two new diclofenac-degrading strains assigned as Serratia proteamaculans AS4 and
Rahnella bruchi AS7 were isolated from the diclofenac-treated AS. | pl_PL |
dc.language.iso | en | pl_PL |
dc.rights | Uznanie autorstwa 3.0 Polska | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/pl/ | * |
dc.subject | activated sludge | pl_PL |
dc.subject | bacterial consortium | pl_PL |
dc.subject | bioaugmentation | pl_PL |
dc.subject | biodegradation | pl_PL |
dc.subject | functional capacity | pl_PL |
dc.subject | non-steroidal anti-inflammatory drugs (NSAIDs) | pl_PL |
dc.subject | paracetamol | pl_PL |
dc.subject | phylogenetic resolution | pl_PL |
dc.title | Effects of Low Concentration of Selected Analgesics and Successive Bioaugmentation of the Activated Sludge on Its Activity and Metabolic Diversity | pl_PL |
dc.type | info:eu-repo/semantics/article | pl_PL |
dc.identifier.doi | 10.3390/W12041133 | - |
Pojawia się w kolekcji: | Artykuły (WNP)
|